Search - tctmd.com

Displaying 601 - 602 of 602

Sort: Relevancy | Date

News Industry News

Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial

September 29, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.